Related Articles
MicroRNA‑15b participates in the development of peripheral arterial disease by modulating the growth of vascular smooth muscle cells
MicroRNA‑208a‑3p participates in coronary heart disease by regulating the growth of hVSMCs by targeting BTG1
MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma
MicroRNA-133a inhibits the malignant behavior of glioma via downregulation of matrix metallopeptidase 9
miR‑125a‑5p inhibits the expression of NLRP3 by targeting CCL4 in human vascular smooth muscle cells treated with ox‑LDL